Our faculty comprises 10 schools, various centres and institutes, each with a unique purpose and focus. We are committed to making maximum impact through an ongoing pursuit of excellence and innovation.
There was much to celebrate when four Monash MBBS students secured internships at the World Health Organisation (WHO) in December. Charlotte O’Leary, Tom Goodwin, Liang Qu and Emily Yeung travelled to Geneva, Switzerland and returned with new insights into global and public health, and another stamp in their passports. Excited about the opportunity to intern at the WHO, Charlotte was keen to live in Geneva with her fellow classmates. “We all knew each other through various means back in Melbourne, largely through the Monash global health community, so when we found out that we were going to be in Geneva together we started planning and have since become close!”
Monash BDI researchers, as part of an international collaboration, have identified a key part of the process by which a common clinical antibiotic is formed – a finding that could potentially pave the way for novel compounds to tackle the problem of bacterial resistance.
From building super grannies to using seaweed to reduce chronic disease risks, the Medicine, Nursing and Health Sciences Three Minute Thesis (3MT) final showcased the incredible calibre of graduate research within our Faculty. Ten finalists, who had won their respective schools’ heats, competed on Thursday July 13 and had just three minutes and one PowerPoint slide to present their thesis.
It is refreshing to see someone go against the grain of society to follow their passion. Remarkable is the first word that comes to mind when describing Aira. Whilst currently completing her studies in nursing and midwifery, Aira is also competing as a professional power lifter.
Do you have a family history of heart disease? Would you like to know how to reduce your risk of this potentially deadly disease? One of Australia’s leading medical research organisations, Baker Heart and Diabetes Institute, is calling on people aged 40-70 years to take part in an innovative research study that aims to advance the prevention and treatment of coronary artery disease.